SCHEMBL8177340

SCHEMBL8177340

S=C1NC(=S)C(=Cc2cc3ccccc3s2)S1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 1/20 0.58
▸ CYP2A6 P11509 1/20 0.46
▸ PIM1 P11309 7/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ PRF1 P14222 2/20 0.41
▸ TDP1 Q9NUW8 2/20 0.40
▸ NAT1 P18440 2/20 0.38
▸ CA2 P00918 1/20 0.38
▸ EPHX1 P07099 1/20 0.38
▸ NSD2 O96028 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HSP90AA1 P07900 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ TUBB4A P04350 2/20 0.35
▸ TUBB P07437 2/20 0.35
▸ TUBA3C P0DPH7 2/20 0.35
▸ TUBA1B P68363 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8177338 1.00 GSK3B (0.58) GSK3BCYP2A6PIM1MEN1KMT2A
SCHEMBL9254893 0.86 GSK3B (0.75) GSK3BPIM1MEN1KMT2ARAB9A
SCHEMBL9254899 0.86 GSK3B (0.75) GSK3BPIM1MEN1KMT2ARAB9A
SCHEMBL8167446 0.73 GSK3B (0.54) GSK3BCYP2A6PIM1MEN1KMT2A
SCHEMBL8177908 0.73 PDE4B (0.46) GSK3BPIM1MEN1KMT2ARAB9A
SCHEMBL8177911 0.73 PDE4B (0.46) GSK3BPIM1MEN1KMT2ARAB9A
SCHEMBL7079637 0.71 CYP2A6 (0.64) GSK3BCYP2A6PRF1CA2TUBB4A
SCHEMBL8173296 0.71 PIM1 (0.51) PIM1MEN1KMT2ARAB9ATDP1
SCHEMBL8173297 0.71 PIM1 (0.51) PIM1MEN1KMT2ARAB9ATDP1
SCHEMBL8173766 0.70 PIM1 (0.74) PIM1MEN1KMT2ARAB9ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018748-A1 RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 — — WO disclosed
Send feedback